During the past decade, Dixon Eye Care conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dixon Eye Care" #1 sponsor was "Santen Inc." with 3 trials, followed by "Formosa Pharmaceuticals, Inc." with 1 trials sponsored, "Kala Pharmaceuticals, Inc." with 1 trials sponsored, "Qlaris Bio, Inc." with 1 trials sponsored and "Salvat" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Dixon Eye Care" are "Ocular Hypertension" (2 trials), "Primary Open Angle Glaucoma" (2 trials), "Cataract" (1 trials), "Dry Eye Syndromes" (1 trials) and "Glaucoma and Ocular Hypertension" (1 trials). Many other conditions were trialed in "Dixon Eye Care" in a lesser frequency.

Most popular intervention types in "Dixon Eye Care" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "DE-117 Ophthalmic Solution" (2 trials), "APP13007, 0.05%" (1 trials), "Clobetasol propionate" (1 trials), "DE-126 Ophthalmic Solution 0.002% QD" (1 trials) and "KPI-121 0.25% Ophthalmic Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dixon Eye Care" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Dixon Eye Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Dixon Eye Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dixon Eye Care, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".